{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:06:50Z","timestamp":1784905610615,"version":"3.55.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.juro.2007.01.031","type":"journal-article","created":{"date-parts":[[2007,4,15]],"date-time":"2007-04-15T07:12:19Z","timestamp":1176621139000},"page":"1727-1731","source":"Crossref","is-referenced-by-count":25,"title":["Patterns of Recurrence and Outcomes Following Induction Bacillus Calmette-Guerin for High Risk Ta, T1 Bladder Cancer"],"prefix":"10.1097","volume":"177","author":[{"given":"Seth P.","family":"Lerner","sequence":"first","affiliation":[{"name":"Scott Department of Urology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Tangen","sequence":"additional","affiliation":[{"name":"Statistical Center, Southwest Oncology Group, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Sucharew","sequence":"additional","affiliation":[{"name":"Statistical Center, Southwest Oncology Group, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[{"name":"Urology Department, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. David","family":"Crawford","sequence":"additional","affiliation":[{"name":"Urology Department, University of Colorado, Boulder, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2007.01.031_bib1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.031_bib2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.031_bib3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0022-5347(01)62517-5","article-title":"Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder","volume":"160","author":"Dinney","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.031_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-5347(05)65969-1","article-title":"Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy","volume":"166","author":"Dutta","year":"2001","journal-title":"J Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2007.01.031_bib5","first-page":"152","article-title":"A phase IIB trial of BCG combined with interferon alpha for bladder cancer","volume":"163","author":"Esuvaranathan","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.031_bib6","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0022-5347(05)65757-6","article-title":"Salvage intravesical therapy with interferon-alpha2b plus low dose bacillus calmette-guerin is effective in patients with superficial bladder cancer in whom bacillus Calmette-Guerin alone previously failed","volume":"166","author":"O\u2019Donnell","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.031_bib7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/01.ju.0000136446.37840.0a","article-title":"Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer","volume":"172","author":"O\u2019Donnell","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.031_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1464-410X.2005.05401.x","article-title":"Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma","volume":"95","author":"Ficarra","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2007.01.031_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1078-1439(03)00144-3","article-title":"Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy","volume":"22","author":"Bianco","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2007.01.031_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-5347(05)67799-3","article-title":"Efficacy and safety of valrubicin for the treatment of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder","volume":"163","author":"Steinberg","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.031_bib11","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/01.ju.0000062605.92268.c6","article-title":"Defining bacillus Calmette-Guerin refractory superficial bladder tumors","volume":"169","author":"Herr","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.031_bib12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2007.01.031_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.urolonc.2005.03.005","article-title":"Quality of life in patients with bladder cancer","volume":"23","author":"Gerharz","year":"2005","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2007.01.031_bib14","first-page":"18","article-title":"Life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion","volume":"19","author":"Hobisch","year":"2001","journal-title":"Semin Urol Oncol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534707000766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534707000766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2007.01.031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:24:55Z","timestamp":1784903095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.juro.2007.01.031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1016\/j.juro.2007.01.031"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2007.01.031","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}